Nomad Foods Limited
12.00USD
-0.2300 (-1.88%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NOMD.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | €0.46▼ | €0.49 | 4 | 0 |
| Next quarter | €0.35▼ | €0.44 | 1 | 3 |
| Current year | €1.43▼ | €1.51 | 2 | 1 |
| Next year | €1.45▼ | €1.62 | 2 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | €0.37 | €0.39 | +0.02 (+4.7%) |
| 2026-03-31 | €0.19 | €0.23 | +0.04 (+24.0%) |
| 2025-12-31 | €0.43 | €0.43 | +0.00 (+0.3%) |
| 2025-09-30 | €0.47 | €0.49 | +0.02 (+5.1%) |
77 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Reiterated | Buy | $15 | Oct 8, 2026 |
| BTIG | Reiterated | Buy | $15 | Aug 14, 2026 |
| Barclays | Maintained | Overweight | $12 $14 | Jul 21, 2026 |
| BTIG | Reiterated | Buy | $15 | May 13, 2026 |
| Barclays | Maintained | Overweight | $13 $12 | Apr 15, 2026 |
| Deutsche Bank | Downgraded from Buy | Hold | $15 $10 | Mar 30, 2026 |
| Mizuho | Maintained | Outperform | $15 $13 | Mar 3, 2026 |
| Barclays | Maintained | Overweight | $15 $13 | Mar 2, 2026 |
| BTIG | Maintained | Buy | $18 $15 | Mar 2, 2026 |
| Mizuho | Maintained | Outperform | $17 $15 | Jan 8, 2026 |
| BTIG | Reiterated | Buy | $18 | Nov 10, 2025 |
| Deutsche Bank | Maintained | Buy | $18 $16 | Nov 7, 2025 |
| BTIG | Maintained | Buy | $20 $18 | Sep 17, 2025 |
| BTIG | Maintained | Buy | $20 $18 | Sep 16, 2025 |
| Mizuho | Maintained | Outperform | $23 $20 | Aug 12, 2025 |
| Barclays | Maintained | Overweight | $20 $18 | Aug 8, 2025 |
| Mizuho | Maintained | Outperform | $26 $23 | Jul 28, 2025 |
| Barclays | Maintained | Overweight | $23 $20 | Jul 15, 2025 |
| Mizuho | Maintained | Outperform | $24 $26 | Mar 4, 2025 |
| Barclays | Maintained | Overweight | $19 $23 | Mar 3, 2025 |
| Barclays | Maintained | Overweight | $21 $19 | Jan 17, 2025 |
| Mizuho | Maintained | Outperform | $28 $24 | Dec 18, 2024 |
| Deutsche Bank | Maintained | Buy | $25 $23 | Nov 4, 2024 |
| Deutsche Bank | Maintained | Buy | $23 $24 | Aug 8, 2024 |
| Barclays | Maintained | Overweight | $22 $21 | Jul 19, 2024 |
11 filings from 9 insiders · 0 buy / 0 sell over 6m
Officers and directors of NOMD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BRISBY DOMINIC JAMESChief Executive Officer | Buy | 50.0k | $12.38 | $619k | Aug 24, 2026 |
| BALDEW RUBEN SEWNARAINChief Financial Officer | Buy | 28.3k | $11.85 | $335k | Aug 19, 2026 |
| LILLIE JAMES EDirector | Grant | 14.0k | — | — | Jun 22, 2026 |
| DORMAN CAREY JDirector | Grant | 22.7k | — | — | Jun 22, 2026 |
| STACK MELANIE DAWNDirector | Grant | 21.9k | — | — | Jun 22, 2026 |
| PILOWSKY AMITDirector | Grant | 21.7k | — | — | Jun 22, 2026 |
| PARRY VICTORIADirector | Grant | 14.0k | — | — | Jun 22, 2026 |
| BRISBY DOMINIC JAMESChief Executive Officer | Buy | 150.0k | $9.79 | $1.47M | May 15, 2026 |
| BALDEW RUBEN SEWNARAINChief Financial Officer | Buy | 14.7k | $9.71 | $143k | May 14, 2026 |
| ASHKEN IAN G HDirector | Buyindirect | 100.0k | $9.13 | $913k | May 13, 2026 |
| GOTTESMAN NOAMChairman of the Board | Buyindirect | 700.0k | $9.23 | $6.63M | May 12, 2026 |
No analyst notes on NOMD yet.
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 2 | 1 | 0 | 0 | Buy1.80 |
| 1 mo ago | 2 | 2 | 1 | 0 | 0 | Buy1.80 |
| 2 mo ago | 2 | 2 | 1 | 0 | 0 | Buy1.80 |
Members whose judged calls on NOMD have played out most reliably.
No settled calls on NOMD yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice